Unbiased AI-powered news
1 stories related to this topic, newest first.
Substrate placeholder — needs reviewModerna has received marketing authorization from the European Commission for MCOMBRIAX, its mRNA combination vaccine against influenza and COVID-19. This enables distribution in European markets. The vaccine targets respiratory viruses with combined protection.